Ars (SPRY) traded down -6.71 % during a 24 hours period ending at 03:59 PM Central Europe on Monday 26th. One Ars stock can currently be bought for about USD 4.01 on popular exchanges. Current supply of Ars stocks is 99.4 mn. Ars has a current market capitalization of USD 400.8 mn and approximately USD 6.1 mn worth of Ars was traded on exchanges in the last 24 hours. Since last month end, Ars has traded -2.89 % down. Simple moving average of last 200 days is at USD 7.59. The highest price of past 52 weeks was recorded at USD 13.15 on 01/12/2026. 52 weeks low was at USD 3.81 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Weyco (WEYS) traded down -2.2 % and now trades at USD 51. Current market capitalisation for Weyco is USD 478.3 mn. Weyco has a current price to earnings ratio of 13.99.
Rice Acquisition (KRSP) traded down -0.29 % and now trades at USD 10.43. Current market capitalisation for Rice Acquisition is USD 479.8 mn.
Arvinas (ARVN) traded down -5.44 % and now trades at USD 7.33. Current market capitalisation for Arvinas is USD 477.3 mn. Current price/earnings ratio for Arvinas is 54.38.
Monopar Therapeutics (MNPR) traded down -2.66 % and now trades at USD 69.54. Current market capitalisation for Monopar Therapeutics is USD 474.2 mn.
Avita Medical (RCEL) traded flat 0 % and now trades at USD 15.07. Avita Medical has a market capitalisation of USD 479.7 mn.
About Ars
ARS Pharmaceuticals, Inc. is a biotechnology company that operates in the Health Care sector. The company is located in San Diego, United States. Their ImmunoTAC technology is designed to create potent therapeutic molecules that can be systemically administered to patients. ARS Pharmaceuticals focuses on patients and healthcare professionals worldwide. You can find more information about them on their website at www.ars-pharma.com and they are listed on the Nasdaq stock exchange.
